Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
NCT02148094 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1325
Last updated 2018-10-11
Summary
Female sex workers (FSWs) in India are at high risk of HIV infection, and while correct and consistent condom use is an effective means of preventing HIV transmission, many FSWs have difficulty insisting on their use. Alternative HIV prevention options are needed for FSWs who are unable to correctly and consistently use condoms with their clients or regular partners. Oral pre-exposure prophylaxis (PrEP) may be an important tool to fill this critical prevention gap, and a demonstration project is required to assess the impact and feasibility of the use of PrEP as an HIV prevention intervention among most at risk FSWs in India.
The proposed project will take place at two sites in India and will assess the use of a risk assessment tool to identify FSWs who would most benefit from PrEP, collect information about the reasons why FSWs choose to accept or decline PrEP, evaluate two different PrEP delivery strategies (weekly clinic pick-up or home delivery by peer educators every second day), monitor adherence to and discontinuation of PrEP, and evaluate unintended consequences of the use of PrEP in these communities (e.g. reduction of condom use, drug side effects or adverse events, social harms or resistance). To ensure the safety of study participants, a community advisory board will be set up and will meet regularly to inform study staff of any concerns that the community may have related to the study, so that the study staff can respond in a timely manner. A data safety and monitoring board will also be established to monitor participant safety.
Conditions
- HIV Infection
Interventions
- DRUG
-
Truvada
The demonstration project will use a prospective cohort design, enrolling individuals and following them up at multiple intervals over the course of 16 months. Study participants will be asked to take one tablet of Truvada daily, as HIV Pre-Exposure Prophylaxis, over this period. They will be asked to attend 7 regular visits at the project sites over the course of the project. In between visits, they will receive peer educator home visits every other day, as part of regular DMSC (Kolkata) and Ashodaya (Mysore/Mandya) outreach prevention activities. We plan to enroll 2000 female sex workers equally split between the two sites.
Sponsors & Collaborators
- collaborator OTHER
-
DMSC
collaborator UNKNOWN -
Ashodaya Samithi
collaborator UNKNOWN -
University of Manitoba
lead OTHER
Principal Investigators
-
Sushena Reza-Paul, MBBS · University of Manitoba, Ashodaya Samithi
-
Smarajit Jana, MBBS · DMSC
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2018-04-30
- Completion
- 2018-06-30
Countries
- India
Study Locations
More Related Trials
-
SCOPE: Strategies to Combine PrEP With Prevention Efforts
NCT01832571 ·Status: WITHDRAWN ·Phase: NA
-
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
NCT02732730 ·Status: COMPLETED ·Phase: PHASE4
-
Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin
NCT02237027 ·Status: COMPLETED ·Phase: PHASE4
-
IPREP Study #2: Evaluating Enhanced PrEP Packages for Young Female Sex Workers in Kisumu, Kenya
NCT03988387 ·Status: COMPLETED ·Phase: NA
-
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
NCT00625404 ·Status: COMPLETED ·Phase: PHASE3
-
Same-Day PrEP Initiation and Sexual Health for Transgender Women
NCT04491422 ·Status: COMPLETED ·Phase: NA
-
Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.
NCT03705663 ·Status: COMPLETED
-
Community-based, Peer-delivered PrEP for Female Sex Workers in Rural Uganda: The Peers for PrEP (P4P) Study
NCT06353295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design
NCT03086057 ·Status: COMPLETED ·Phase: NA
-
PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation
NCT03253757 ·Status: UNKNOWN
-
Prevention of HIV in "Île-de-France"
NCT03113123 ·Status: UNKNOWN ·Phase: NA
-
Project Engage: Oral PrEP Acceptability
NCT05458765 ·Status: COMPLETED ·Phase: PHASE2
-
PrEP Among MSM and TG in Myanmar
NCT04781426 ·Status: COMPLETED
-
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
NCT04760691 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
NCT01772823 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing PrEP Uptake and Adherence Among Male Sex Workers
NCT05736614 ·Status: RECRUITING ·Phase: NA
-
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
NCT07002866 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women
NCT06996938 ·Status: RECRUITING ·Phase: NA
-
Pre-exposure Option for Reducing HIV in the UK.(PROUD)
NCT02065986 ·Status: COMPLETED ·Phase: PHASE4
-
The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study
NCT06743204 ·Status: RECRUITING ·Phase: NA
-
PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention
NCT04902820 ·Status: COMPLETED ·Phase: NA
-
The Prevention Options for Women Evaluation Research (POWER) Cohort
NCT03490058 ·Status: COMPLETED
-
Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women
NCT04396678 ·Status: COMPLETED ·Phase: NA
-
Pre-Exposure Prophylaxis for Transgender Women in the US and South America
NCT04742491 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
NCT01473472 ·Status: COMPLETED ·Phase: PHASE3